Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-05-000233
Filing Date
2005-02-11
Accepted
2005-02-11 13:36:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS osip1231i.htm SC 13G 35196
  Complete submission text file 0000019617-05-000233.txt   37682
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 39TH FL NEW YORK NY 10017 2122706000
J P MORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 05596899
SIC: 2835 In Vitro & In Vivo Diagnostic Substances